SCHEMBL1245253

SCHEMBL1245253

CCOC(=O)N(c1cccc(Br)c1)c1c(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2)noc1C

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CACNA1F O60840 3/20 0.42
CACNA1D Q01668 3/20 0.42
CACNA1S Q13698 3/20 0.42
CACNA1C Q13936 3/20 0.42
ABCB1 P08183 2/20 0.42
TSHR P16473 1/20 0.37
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
NR1H4 Q96RI1 3/20 0.36
ALDH1A1 P00352 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
PPARD Q03181 1/20 0.35
LPAR1 Q92633 1/20 0.35
ENPP2 Q13822 2/20 0.34
DGAT1 O75907 1/20 0.34
GABRA5 P31644 1/20 0.34
SCN9A Q15858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1247415 0.90 TSHR (0.43) CACNA1FCACNA1DCACNA1SCACNA1CTSHR
SCHEMBL1247195 0.87 HDAC1 (0.43)
SCHEMBL2338529 0.85 LPAR1 (0.44) CACNA1FCACNA1DCACNA1SCACNA1CABCB1
SCHEMBL1247166 0.85 TSHR (0.44) CACNA1FCACNA1DCACNA1SCACNA1CTSHR
SCHEMBL1247291 0.83 SCN9A (0.41) CACNA1FCACNA1DCACNA1SCACNA1CTSHR
SCHEMBL1246323 0.81 PPARD (0.39) CACNA1FCACNA1DCACNA1SCACNA1CTSHR
SCHEMBL1247569 0.81 SCN9A (0.39) CACNA1FCACNA1DCACNA1SCACNA1CNR1H4
SCHEMBL1245270 0.80 KDM4E (0.44) CACNA1FCACNA1DCACNA1SCACNA1CTSHR
SCHEMBL1245358 0.80 NR1H4 (0.42) CYP2C19NR1H4ALDH1A1PPARDLPAR1
SCHEMBL1247349 0.79 GPBAR1 (0.39) CACNA1FCACNA1DCACNA1SCACNA1CTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2462128-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-06-13 EP claimed
WO-2011017350-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-02-10 WO claimed